Journal of Innovative Optical Health Sciences, 2015, 8 (1): 1530001, Published Online: Jul. 15, 2020  

Elsinochrome A photosensitizers: Alternative drugs for photodynamic therapy

Author Affiliations
1 Department of Laser Medicine, Chinese PLA General Hospital, Beijing, People's Republic of China 100853
2 Department of Dermatology, 309 Hospital of PLA,
3 Beijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Photochemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, People's Republic of China 100190
Abstract
Photodynamic therapy (PDT) has already been a multifunctional modality for various tumors and nontumorous diseases. However, the development of photosensitizers is relatively delayed, compared with the tremendous progress in laser technology. Elsinochrome A (EA), a perylenequinonoid pigment from China, has all the typical advantages of perylenequinones. Moreover, singlet oxygen quantum yield of EA is superior to other kinds of photosensitizers and EA could be artificially biosynthesized at present, which make it an alternative candidate for PDT. In this review, the photophysics, photochemistry, photobiology and chemical or biological syntheses of EA photosensitizers are briefly presented. Besides, the future prospects of EA photosensitizers are also proposed.

Tinghui Li, Hong Deng, Jingquan Zhao, Ying Gu. Elsinochrome A photosensitizers: Alternative drugs for photodynamic therapy[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1530001.

关于本站 Cookie 的使用提示

中国光学期刊网使用基于 cookie 的技术来更好地为您提供各项服务,点击此处了解我们的隐私策略。 如您需继续使用本网站,请您授权我们使用本地 cookie 来保存部分信息。
全站搜索
您最值得信赖的光电行业旗舰网络服务平台!